PDB1VAR; Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ, Boissinot M, Hallewell RA, Lepock JR, Cabelli DE, Tainer JA. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry. April 1996, 35 (14): 4287–97. PMID 8605177. doi:10.1021/bi951892w.
PDB1SDY; Djinović K, Gatti G, Coda A, Antolini L, Pelosi G, Desideri A, Falconi M, Marmocchi F, Rolilio G, Bolognesi M. Structure solution and molecular dynamics refinement of the yeast Cu,Zn enzyme superoxide dismutase. Acta Crystallogr., B. December 1991, 47 (6): 918–27. PMID 1772629. doi:10.1107/S0108768191004949.
Borgstahl GE, Parge HE, Hickey MJ, Beyer WF, Hallewell RA, Tainer JA. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell. October 1992, 71 (1): 107–18. PMID 1394426. doi:10.1016/0092-8674(92)90270-M.
PDB2JLP; Antonyuk SV, Strange RW, Marklund SL, Hasnain SS. The structure of human extracellular copper-zinc superoxide dismutase at 1.7 A resolution: insights into heparin and collagen binding. J. Mol. Biol. May 2009, 388 (2): 310–26. PMID 19289127. doi:10.1016/j.jmb.2009.03.026.
(英文)Li, Y.; et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase.. Nat. Genet. 1995, 11: 376–381. doi:10.1038/ng1295-376. 引文格式1维护:显式使用等标签 (link)
(英文)Elchuri, S.; et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life.. Oncogene. 2005, 24: 367–380. doi:10.1038/sj.onc.1208207. 引文格式1维护:显式使用等标签 (link)
(英文)Muller, F. L.; et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress, mutagenesis and acceleration of age-dependent skeletal muscle atrophy.. Free Radic. Biol. Med. 2006, 40: 1993–2004. doi:10.1016/j.freeradbiomed.2006.01.036. 引文格式1维护:显式使用等标签 (link)
(英文)Sentman, M. L.; et al. Phenotypes of mice lacking extracellular superoxide dismutase and copper- and zinc-containing superoxide dismutase. J. Biol. Chem. 2006, 281: 6904–6909. doi:10.1074/jbc.M510764200. 引文格式1维护:显式使用等标签 (link)
(英文)Conwit, Robin A. Preventing familial ALS: A clinical trial may be feasible but is an efficacy trial warranted?. Journal of the Neurological Sciences. December 2006, 251 (1–2): 1–2. ISSN 0022-510X. doi:10.1016/j.jns.2006.07.009.
(英文)Vozenin-Brotons MC; Sivan V, Gault N, Renard C, Geffrotin C, Delanian S, Lefaix JL, Martin M. Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med (Elsevier). 2001, 30 (1): 30–42. PMID 11134893. doi:10.1016/S0891-5849(00)00431-7.引文使用过时参数coauthors (帮助)
PDB1VAR; Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ, Boissinot M, Hallewell RA, Lepock JR, Cabelli DE, Tainer JA. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry. April 1996, 35 (14): 4287–97. PMID 8605177. doi:10.1021/bi951892w.
PDB1SDY; Djinović K, Gatti G, Coda A, Antolini L, Pelosi G, Desideri A, Falconi M, Marmocchi F, Rolilio G, Bolognesi M. Structure solution and molecular dynamics refinement of the yeast Cu,Zn enzyme superoxide dismutase. Acta Crystallogr., B. December 1991, 47 (6): 918–27. PMID 1772629. doi:10.1107/S0108768191004949.
Borgstahl GE, Parge HE, Hickey MJ, Beyer WF, Hallewell RA, Tainer JA. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell. October 1992, 71 (1): 107–18. PMID 1394426. doi:10.1016/0092-8674(92)90270-M.
PDB2JLP; Antonyuk SV, Strange RW, Marklund SL, Hasnain SS. The structure of human extracellular copper-zinc superoxide dismutase at 1.7 A resolution: insights into heparin and collagen binding. J. Mol. Biol. May 2009, 388 (2): 310–26. PMID 19289127. doi:10.1016/j.jmb.2009.03.026.
(英文)Vozenin-Brotons MC; Sivan V, Gault N, Renard C, Geffrotin C, Delanian S, Lefaix JL, Martin M. Antifibrotic action of Cu/Zn SOD is mediated by TGF-beta1 repression and phenotypic reversion of myofibroblasts. Free Radic Biol Med (Elsevier). 2001, 30 (1): 30–42. PMID 11134893. doi:10.1016/S0891-5849(00)00431-7.引文使用过时参数coauthors (帮助)
rcsb.org
PDB1VAR; Borgstahl GE, Parge HE, Hickey MJ, Johnson MJ, Boissinot M, Hallewell RA, Lepock JR, Cabelli DE, Tainer JA. Human mitochondrial manganese superoxide dismutase polymorphic variant Ile58Thr reduces activity by destabilizing the tetrameric interface. Biochemistry. April 1996, 35 (14): 4287–97. PMID 8605177. doi:10.1021/bi951892w.
PDB1SDY; Djinović K, Gatti G, Coda A, Antolini L, Pelosi G, Desideri A, Falconi M, Marmocchi F, Rolilio G, Bolognesi M. Structure solution and molecular dynamics refinement of the yeast Cu,Zn enzyme superoxide dismutase. Acta Crystallogr., B. December 1991, 47 (6): 918–27. PMID 1772629. doi:10.1107/S0108768191004949.
PDB2JLP; Antonyuk SV, Strange RW, Marklund SL, Hasnain SS. The structure of human extracellular copper-zinc superoxide dismutase at 1.7 A resolution: insights into heparin and collagen binding. J. Mol. Biol. May 2009, 388 (2): 310–26. PMID 19289127. doi:10.1016/j.jmb.2009.03.026.
(英文)Conwit, Robin A. Preventing familial ALS: A clinical trial may be feasible but is an efficacy trial warranted?. Journal of the Neurological Sciences. December 2006, 251 (1–2): 1–2. ISSN 0022-510X. doi:10.1016/j.jns.2006.07.009.
(英文)Al-Chalabi, Ammar; P. Nigel Leigh. Recent advances in amyotrophic lateral sclerosis. Current Opinion in Neurology. August 2000, 13 (4): 397–405. ISSN 1473-6551.引文使用过时参数coauthor (帮助)